Mark Mallon - Chief Executive Officer, Director at Neogenomics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
NEO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark Mallon since 11/3/2023

Holdings reported by Mark Mallon for Neogenomics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 368K $6.77M $18.39 Mar 1, 2022 Direct
Stock Option (Right to Buy) 348K Mar 1, 2022 Direct Common Stock 151K

Transactions reported by Mark Mallon for Neogenomics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.